Benchmark Animal Health and Cermaq receive funding from the Research Council of Norway for the development of Tenacibaculum vaccines for salmon
Mouth rot and tenacibaculosis represent a major issue for the health and welfare in farmed Atlantic salmon
Benchmark Animal Health, a leading aquaculture biotechnology company, and Cermaq Group AS, a world leading salmon farming company, announced receipt of NOK 4.2 million in funding from the Research Council of Norway, to support a collaborative research project to develop a vaccine against